SecBot SecBot
144 ·Filed May 15, 2026

OM

Outset Medical, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001304125-26-000005
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine sell-to-cover transaction for tax withholding on RSU vesting, not a discretionary insider sale. No material signal for traders. Monitor for any future discretionary Form 4 filings by the CEO, which would carry more weight.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
OM ▲ +20.97% at T+60d
NEUTRAL call +20.97% · α vs SPY +16.12% · entry $3.72 → $4.50
Entry = T+0 close
May 15, 2026
via day close
T+1d
+3.76%
call +3.76% · α +4.41%
$3.86
settled 5mo ago
T+5d
+18.28%
call +18.28% · α +16.66%
$4.40
settled 5mo ago
T+20d
+18.55%
call +18.55% · α +16.97%
$4.41
settled 4mo ago
T+60d
+20.97%
call +20.97% · α +16.12%
$4.50
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

CEO Leslie Trigg filed a Form 144 to sell 3,445 shares of Outset Medical common stock, with an estimated aggregate market value of $12,746.50. The sale is tied to the settlement of vested restricted stock units (RSUs) and is described as a 'sell to cover' transaction for tax withholding obligations, not a discretionary trade. Given the small dollar amount relative to the company's $71M market cap and the non-discretionary nature, this filing is routine and carries minimal trading signal.

Key Facts

  • CEO Leslie Trigg filed a Form 144 to sell 3,445 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $12,746.50.
  • The sale is to satisfy tax withholding obligations upon vesting of RSUs (sell-to-cover).
  • A prior sell-to-cover transaction of 3,384 shares occurred on 02/17/2026 for $11,336.40.
  • Company market cap is approximately $71M; the sale represents ~0.02% of market cap.
  • The filing explicitly states the transaction 'does not represent a discretionary trade by the reporting person.'

Financial Impact

Proposed sale of $12,746.50, representing ~0.02% of the company's $71M market cap.

dilution

Risk Factors

  • None material from this filing; the sale is non-discretionary and de minimis.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
75% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001304125-26-000005
Document: 0001304125-26-000005-index.html0001304125-26-000005
Document: 0001304125-26-000005.txt0001304125-26-000005
10 reports for OM
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OM — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$4.17awaiting T+5—$4.08 (−2.16%)
Oct 6, 2026
19d ago
SC 13G/A
BULLISH ★ 5/10
$4.21 $3.84▼ −8.79%▼ −7.81%$4.08 (−3.09%)
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$3.82 $3.47▼ −9.16%▼ −9.02%$4.08 (+6.81%)
Aug 14, 2026
10w ago
144
BEARISH ★ 5/10
$4.51 $4.19▲ +7.10%▲ +5.90%$4.08 (+9.53%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$4.30 $4.02▼ −6.51%▼ −6.95%$4.08 (−5.12%)
May 19, 2026
22w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.38 $5.01▲ +14.38%▲ +12.58%$4.08 (−6.85%)
May 15, 2026
23w ago
144
NEUTRAL ★ 2/10
$3.72 $4.40▲ +18.28%▲ +16.66%$4.08 (+9.68%)
Apr 27, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$4.32 $4.33▲ +0.23%▼ −1.46%$4.08 (−5.56%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$4.41 $4.33▼ −1.81%▼ −2.21%$4.08 (−7.48%)
Apr 8, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$4.32 $4.40▲ +1.85%▼ −1.33%$4.08 (−5.56%)
Showing 10 of 10

US Market Status

Market Closed — Opens Tue (16h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026